BioMarin Pharmaceutical Price Target Maintained With a $89.00/Share by Canaccord Genuity
Biomarin Pharmaceutical Analyst Ratings
A Quick Look at Today's Ratings for Lennox International(LII.US), With a Forecast Between $570 to $597
Loop Capital Maintains Carlisle Companies(CSL.US) With Buy Rating, Maintains Target Price $475
Oppenheimer Maintains Carlisle Companies(CSL.US) With Buy Rating, Raises Target Price to $475
Carlisle Companies (CSL) Receives a Rating Update From a Top Analyst
Analysts Offer Insights on Industrial Goods Companies: Nordson (NDSN) and Carlisle Companies (CSL)
Oppenheimer Keeps Their Hold Rating on Lennox International (LII)
CCORF Maintains Biomarin Pharmaceutical(BMRN.US) With Hold Rating, Cuts Target Price to $89
Buy Rating Affirmed for Lennox International With Upgraded Earnings and Target Price Amid Strong Q2 Performance
Analysts Offer Insights on Industrial Goods Companies: General Dynamics (GD), Old Dominion Freight (ODFL) and Lennox International (LII)
Analysts Offer Insights on Industrial Goods Companies: Reliance Worldwide Corp. Ltd. (OtherRLLWF), Lindab International AB (GB:0MWK) and Electro Optic Systems Holdings Limited (OtherEOPSF)
Lennox International (LII) Receives a Buy From KeyBanc
Loop Capital Adjusts Price Target on Manhattan Associates to $265 From $250, Maintains Buy Rating
Manhattan Associates Price Target Raised to $265.00/Share From $250.00 by Loop Capital
Loop Capital Maintains Manhattan Associates(MANH.US) With Buy Rating, Raises Target Price to $265
D.A. Davidson Maintains Manhattan Associates(MANH.US) With Buy Rating
Manhattan Associates Analyst Ratings
A Quick Look at Today's Ratings for Manhattan Associates(MANH.US), With a Forecast Between $261 to $265
William Blair Sticks to Their Hold Rating for Manhattan Associates (MANH)